Replies to post #175680 on Pervasip Corp (PVSP)

[Bjones2]

Just converted $1.5M at .01 per share

Cannabis companies have been valued as high as 10 times trailing revenue, as most are growing at high rates from 50 to 100%.

Even now when most are down 80% from recent highs last year, the typical valuation has dropped as low as 2.5 trailing revenue.

PVSP has trailing revenue of $17M with forward revenue projection of nearly $40M for 2022 with new expansion of growing facilities and multi state expansion.

Valuations are forward looking, and PVSP is looking at $50M valuation with price of .01, recently it's market value was $8M, less than physical assets, and less than 50% of trailing revenue.

Debt conversion was part of the reason but that debt was being converted to clean up the new company balance sheet.

We are an early stage start up, 5 years old. Profitability is NOT a the goal right now, GROWTH is the goal. Do you think Tesla, or Amazon was worried about Profitability for the first 10 years?
Of course not, profitability comes from SCALE.

You should be looking at GROWTH, 100% a year is fantastic!

[dolly2]

I CAN'T either. LOL

[zombywolf]

That they even have net income puts this stock in the top 10% of the OTC. Same goes for assets-$11 million, without BS like Goodwill included. Lets compare this with a competitor in the same market-Cresco. Cresco has assets of about $1.5 million, with about 25% of that Goodwill. Their revenue was $600,000 two months short of here in 2021-add a couple hundred thousand for October and November= around $800,000 vs $17 million here. That company also has a net loss like the other 90% of the OTC, unlike here. Their share price is $6 per share, adjusted for share structure is .328 per share. Current price for $PSVP is .002. What were you referring to about undervalued? .328 vs .002 with those comparisons?